June 07, 2024 / 12:15 IST
Reported Standalone quarterly numbers for Beryl Drugs are:Net Sales at Rs 2.98 crore in March 2024 down 51.3% from Rs. 6.11 crore in March 2023.
Story continues below Advertisement
Quarterly Net Loss at Rs. 0.35 crore in March 2024 down 649.37% from Rs. 0.06 crore in March 2023.
EBITDA stands at Rs. 0.03 crore in March 2024 down 88.89% from Rs. 0.27 crore in March 2023.
Beryl Drugs shares closed at 31.09 on June 06, 2024 (BSE) and has given 24.51% returns over the last 6 months and 107.27% over the last 12 months.
| Beryl Drugs | | Standalone Quarterly Results | in Rs. Cr. |
|
| Mar'24 | Dec'23 | Mar'23 | | Net Sales/Income from operations | 2.98 | 7.62 | 6.11 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 2.98 | 7.62 | 6.11 | | EXPENDITURE | | Consumption of Raw Materials | 2.88 | 3.51 | 3.34 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | 0.14 | -0.30 | -0.10 | | Power & Fuel | -- | -- | -- | | Employees Cost | 0.49 | 0.55 | 0.45 | | Depreciation | 0.32 | 0.31 | 0.15 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | -0.33 | 3.11 | 2.13 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -0.52 | 0.45 | 0.14 | | Other Income | 0.23 | 0.04 | -0.02 | | P/L Before Int., Excpt. Items & Tax | -0.29 | 0.49 | 0.12 | | Interest | 0.13 | 0.11 | 0.06 | | P/L Before Exceptional Items & Tax | -0.42 | 0.38 | 0.06 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -0.42 | 0.38 | 0.06 | | Tax | -0.08 | 0.07 | 0.00 | | P/L After Tax from Ordinary Activities | -0.35 | 0.31 | 0.06 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -0.35 | 0.31 | 0.06 | | Equity Share Capital | 5.07 | 5.07 | 5.07 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -0.68 | 0.61 | 0.12 | | Diluted EPS | -0.68 | 0.61 | 0.12 | | EPS After Extra Ordinary | | Basic EPS | -0.68 | 0.61 | 0.12 | | Diluted EPS | -0.68 | 0.61 | 0.12 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
